Producto añadido correctamente al carrito.

discount label
Ac-CAF-NH2
Ver en 3D

Biosynth logo

Ac-CAF-NH2

Ref. 3D-PP44503

Tamaño no definidoA consultar
Entrega estimada en Estados Unidos, el Lunes 2 de Diciembre de 2024

Información del producto

Nombre:
Ac-CAF-NH2
Sinónimos:
  • Ac-Cys-Ala-Phe-amide
Descripción:

Peptide Ac-CAF-NH2 is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using Ac-CAF-NH2 include the following: Cancer-associated fibroblast (CAF) heterogeneity and targeting therapy of CAFs in pancreatic cancer X Geng, H Chen, L Zhao, J Hu, W Yang, G Li - Frontiers in cell and , 2021 - frontiersin.orghttps://www.frontiersin.org/articles/10.3389/fcell.2021.655152/full Prime-pull immunization with a bivalent M-protein and spy-CEP peptide vaccine adjuvanted with CAF® 01 liposomes induces both mucosal and peripheral protection V Ozberk , S Reynolds, Y Huo, A Calcutt, S Eskandari - Mbio, 2021 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/mbio.03537-20 Kallikrein-related peptidase 4 induces cancer-associated fibroblast features in prostate-derived stromal cells T Kryza , LM Silva , N Bock - Molecular , 2017 - Wiley Online Libraryhttps://febs.onlinelibrary.wiley.com/doi/abs/10.1002/1878-0261.12075 First in man study: Bcl-Xl_42-CAF®09b vaccines in patients with locally advanced prostate cancer SK Mork, P Kongsted, MCW Westergaard - Frontiers in , 2023 - frontiersin.orghttps://www.frontiersin.org/articles/10.3389/fimmu.2023.1122977/full Personalized therapy with peptide-based neoantigen vaccine (EVX-01) including a novel adjuvant, CAF® 09b, in patients with metastatic melanoma SK Mork, M Kadivar, KF Bol , A Draghi - , 2022 - Taylor & Francishttps://www.tandfonline.com/doi/abs/10.1080/2162402X.2021.2023255 Insights on HIV-1 Tat: P/CAF bromodomain molecular recognition from in vivo experiments and molecular dynamics simulations S Pantano , A Marcello, A Ferrari - Proteins: Structure , 2006 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/prot.20805 Immune Responses to Pandemic H1N1 Influenza Virus Infection in Pigs Vaccinated with a Conserved Hemagglutinin HA1 Peptide Adjuvanted with CAF®01 or CDA S Lopez-Serrano, L Cordoba, M Perez-Maillo - Vaccines, 2021 - mdpi.comhttps://www.mdpi.com/2076-393X/9/7/751 Breast tumor cell invasion and pro-invasive activity of cancer-associated fibroblasts co-targeted by novel urokinase-derived decapeptides S Belli, P Franco, F Iommelli, A De Vincenzo - Cancers, 2020 - mdpi.comhttps://www.mdpi.com/2072-6694/12/9/2404 Three-dimensional cell culture conditions affect the proteome of cancer-associated fibroblasts RC Tölle, C Gaggioli , J Dengjel - Journal of proteome research, 2018 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/acs.jproteome.8b00237 Cancer-associated fibroblasts: Origin, function, imaging, and therapeutic targeting R Rimal , P Desai , R Daware, A Hosseinnejad - Advanced drug delivery , 2022 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0169409X22003945 Fibrotic activity quantified in serum by measurements of type III collagen pro-peptides can be used for prognosis across different solid tumor types N Willumsen , C Jensen, G Green, NI Nissen - Cellular and Molecular , 2022 - Springerhttps://link.springer.com/article/10.1007/s00018-022-04226-0 Fibroblast activation protein-alpha, a stromal cell surface protease, shapes key features of cancer associated fibroblasts through proteome and degradome MM Koczorowska, S Tholen , F Bucher, L Lutz - Molecular , 2016 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S1574789115001477 Nano-strategies to target breast cancer-associated fibroblasts: rearranging the tumor microenvironment to achieve antitumor efficacy M Truffi, S Mazzucchelli, A Bonizzi, L Sorrentino - International journal of , 2019 - mdpi.comhttps://www.mdpi.com/1422-0067/20/6/1263 CAF-secreted annexin A1 induces prostate cancer cells to gain stem cell-like features LA Geary, KA Nash, H Adisetiyo, M Liang, CP Liao - Molecular cancer , 2014 - AACRhttps://aacrjournals.org/mcr/article-abstract/12/4/607/89481 Targeting cancer associated fibroblasts in liver fibrosis and liver cancer using nanocarriers L Kaps, D Schuppan - Cells, 2020 - mdpi.comhttps://www.mdpi.com/2073-4409/9/9/2027 Kinetic mechanism of human histone acetyltransferase P/CAF KG Tanner, MR Langer, JM Denu - Biochemistry, 2000 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/bi001272h Pancreatic cancer associated fibroblasts (CAF): under-explored target for pancreatic cancer treatment J Norton, D Foster , M Chinta, A Titan , M Longaker - Cancers, 2020 - mdpi.comhttps://www.mdpi.com/2072-6694/12/5/1347 Reshaping Prostate Tumor Microenvironment To Suppress Metastasis via Cancer-Associated Fibroblast Inactivation with Peptide-Assembly-Based Nanosystem J Lang , X Zhao, Y Qi, Y Zhang, X Han , Y Ding, J Guan - ACS , 2019 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/acsnano.9b04857 Human breast cancer-associated fibroblasts (CAFs) show caveolin-1 down-regulation and RB tumor suppressor functional inactivation: implications for the response I Mercier , MC Casimiro, C Wang - Cancer biology & , 2008 - Taylor & Francishttps://www.tandfonline.com/doi/abs/10.4161/cbt.7.8.6220 Opportunities and delusions regarding drug delivery targeting pancreatic cancer-associated fibroblasts H Liu, Y Shi , F Qian - Advanced Drug Delivery Reviews, 2021 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0169409X21000582 The human histone acetyltransferase P/CAF is a promiscuous histone propionyltransferase H Leemhuis , LC Packman, KP Nightingale - , 2008 - academia.eduhttps://www.academia.edu/download/48873813/The_Human_Histone_Acetyltransferase_PCAF20160915-26813-1aofmdp.pdf Proteomic profiling of human prostate Cancer-associated fibroblasts (CAF) reveals LOXL2-dependent regulation of the tumor microenvironment*[S] EV Nguyen, BA Pereira , MG Lawrence , X Ma - Molecular & Cellular , 2019 - ASBMBhttps://www.mcponline.org/article/S1535-9476(20)31548-6/fulltext Targeting cancer-associated fibroblasts in immunotherapy D Kim , Y Wu, YK Oh - Systemic Drug Delivery Strategies, 2022 - Elsevierhttps://www.sciencedirect.com/science/article/pii/B9780323857819000075 Regulating cancer associated fibroblasts with losartan-loaded injectable peptide hydrogel to potentiate chemotherapy in inhibiting growth and lung metastasis of triple C Hu, X Liu, W Ran, J Meng, Y Zhai, P Zhang , Q Yin - Biomaterials, 2017 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0142961217305112 Quantitative proteomic profiling of primary cancer-associated fibroblasts in oesophageal adenocarcinoma A Manousopoulou , A Hayden, M Mellone - British journal of , 2018 - nature.comhttps://www.nature.com/articles/s41416-018-0042-9

Aviso:
Nuestros productos están destinados únicamente para uso en laboratorio. Para cualquier otro uso, por favor contáctenos.
Marca:
Biosynth
Almacenamiento de larga duración:
Notas:

Propiedades químicas

MDL:
Punto de fusión:
Punto de ebullición:
Punto de inflamabilidad:
Densidad:
Concentración:
EINECS:
Merck:
Código HS:

Información de peligrosidad

Número UN:
Cantidad exceptuada (EQ):
Clase:
Frases H:
Frases P:
Prohibido volar:
Información de peligrosidad:
Grupo de empaquetado:
Cantidad limitada (LQ):

Consulta técnica sobre: 3D-PP44503 Ac-CAF-NH2

Use el carrito para solicitar presupuestos o pedidos

Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.

* Campos obligatorios
¡Bienvenido a CymitQuimica!Utilizamos cookies para mejorar su visita. No incluimos publicidad.

Consulte nuestra Política de Cookies para obtener más información o ajuste sus preferencias en "Configurar".